Medigene AG
MDGEF · OTC
6/30/2024 | 12/31/2023 | 6/30/2023 | 12/31/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$6,726 | -$9,207 | -$6,970 | -$22,249 |
| Dep. & Amort. | $703 | $792 | $671 | $21,106 |
| Deferred Tax | $0 | -$396 | -$566 | -$44,109 |
| Stock-Based Comp. | $109 | $165 | $142 | $175 |
| Change in WC | $930 | $1,399 | -$1,402 | -$2,709 |
| Other Non-Cash | -$2,104 | $162 | -$475 | -$1,649 |
| Operating Cash Flow | -$7,088 | -$7,085 | -$8,034 | -$5,326 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$302 | -$319 | -$345 | -$725 |
| Net Acquisitions | $0 | $48 | $0 | $2 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $3,000 | $0 |
| Other Inv. Act. | $8,000 | $100 | $2,900 | -$51 |
| Investing Cash Flow | $7,698 | -$171 | $2,555 | -$776 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$1,170 | $0 | -$163 | $0 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $5,895 | -$613 | $0 | -$24 |
| Financing Cash Flow | $4,725 | -$613 | -$163 | -$24 |
| Forex Effect | $15 | -$7 | -$32 | -$33 |
| Net Chg. in Cash | $14,024 | -$7,876 | -$5,674 | -$6,159 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $0 | $16,550 | $22,224 | $28,383 |
| End Cash | $14,024 | $8,674 | $16,550 | $22,224 |
| Free Cash Flow | -$7,390 | -$7,404 | -$8,379 | -$6,051 |